Changes in patterns of infection associated with pediatric idiopathic nephrotic syndrome: a single-center experience in Japan.

[1]  K. Kamei,et al.  The association between hypogammaglobulinemia severity and infection risk in rituximab-treated patients with childhood-onset idiopathic nephrotic syndrome , 2022, Pediatric Nephrology.

[2]  K. Ault,et al.  Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2022 , 2022, MMWR. Morbidity and mortality weekly report.

[3]  Jillian K. Warejko,et al.  An initiative to improve pneumococcal immunization counseling in children with nephrotic syndrome , 2021, Pediatric Nephrology.

[4]  A. Ishiguro,et al.  Incidence and risk factors of rituximab-associated hypogammaglobulinemia in patients with complicated nephrotic syndrome , 2021, Pediatric Nephrology.

[5]  Chi-Jung Chung,et al.  Infections and risk of end-stage renal disease in patients with nephrotic syndrome: a nationwide population-based case-control study , 2020, Annals of translational medicine.

[6]  V. Manchanda,et al.  Incidence and risk factors for major infections in hospitalized children with nephrotic syndrome , 2019, Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia.

[7]  S. Ito,et al.  Rituximab therapy for refractory steroid-resistant nephrotic syndrome in children , 2018, Pediatric Nephrology.

[8]  D. Selewski,et al.  Association of infections and venous thromboembolism in hospitalized children with nephrotic syndrome , 2018, Pediatric Nephrology.

[9]  R. Parekh,et al.  Idiopathic nephrotic syndrome in children , 2018, The Lancet.

[10]  M. Neuman,et al.  Does This Child Have Pneumonia?: The Rational Clinical Examination Systematic Review , 2017, JAMA.

[11]  G. Choukroun,et al.  Infectious complications of a rituximab-based immunosuppressive regimen in patients with glomerular disease , 2016, Clinical kidney journal.

[12]  S. Ito,et al.  Rituximab-associated agranulocytosis in children with refractory idiopathic nephrotic syndrome: case series and review of literature. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  R. Mori,et al.  Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial , 2014, The Lancet.

[14]  J. Mandal,et al.  Clinical spectrum and predictive risk factors of major infections in hospitalized children with nephrotic syndrome , 2013, Indian Pediatrics.

[15]  B. Kerlin,et al.  Increasing frequency of acute kidney injury amongst children hospitalized with nephrotic syndrome , 2013, Pediatric Nephrology.

[16]  A. C. Tsai,et al.  Occurrence of infection among children with nephrotic syndrome during hospitalizations , 2012, Nephrology.

[17]  L. Greenbaum,et al.  Childhood nephrotic syndrome—current and future therapies , 2012, Nature Reviews Nephrology.

[18]  S. Ito,et al.  Atypical Pneumocystis jiroveci pneumonia with multiple nodular granulomas after rituximab for refractory nephrotic syndrome , 2012, Pediatric Nephrology.

[19]  B. Kasiske,et al.  KDIGO Clinical Practice Guideline for Glomerulonephritis , 2012 .

[20]  A. Noyan,et al.  Primary peritonitis in children with nephrotic syndrome: results of a 5-year multicenter study , 2009, European Journal of Pediatrics.

[21]  S. Looney,et al.  Comparison of Incidence of Invasive Streptococcus pneumoniae Disease Among Children Before and After Introduction of Conjugated Pneumococcal Vaccine , 2005, The Pediatric infectious disease journal.

[22]  M. Mufson,et al.  EPIDEMIOLOGY OF INVASIVE STREPTOCOCCUS PNEUMONIAE INFECTIONS AND VACCINE IMPLICATIONS AMONG CHILDREN IN A WEST VIRGINIA COMMUNITY, 1978–2003 , 2004, The Pediatric infectious disease journal.

[23]  T. Masaoka.  Evidence-based recommendations for antimicrobial use in febrile neutropenia in Japan: executive summary. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  B. Rath,et al.  Clinical profile of children with nephrotic syndrome not on glucorticoid therapy, but presenting with infection , 2004, Journal of paediatrics and child health.

[25]  Y. Tain,et al.  Microbiological spectrum of septicemia and peritonitis in nephrotic children , 1999, Pediatric Nephrology.

[26]  M. Ballow,et al.  Serum hemolytic factor D values in children with steroid-responsive idiopathic nephrotic syndrome. , 1982, The Journal of pediatrics.

[27]  N. Halsey,et al.  Serum antibody response to pneumococcal vaccine in children with nephrotic syndrome. , 1982, Pediatrics.

[28]  A. Michael,et al.  Decreased Serum Factor B Concentration Associated with Decreased Opsonization of Escherichia coli in the Idiopathic Nephrotic Syndrome , 1977, Pediatric Research.

[29]  R. W. Archibald,et al.  Fatal systemic measles in a child receiving cyclophosphamide for nephrotic syndrome. , 1969, Lancet.

[30]  C. Janeway,et al.  NEPHROTIC SYNDROME , 1950, Pediatrics.